Description of the blood test:

Anti-Endomysial Antibodies (EMA) are autoantibodies produced by the immune system in response to gluten consumption in genetically susceptible individuals. These antibodies target the endomysium—the thin layer of connective tissue that surrounds individual muscle fibers in the lining of the intestine. Because EMA is highly specific to the damage caused by gluten, it is considered one of the most accurate blood markers for diagnosing Celiac disease and Dermatitis Herpetiformis (a gluten-related skin condition).

What Does the Test Represent?

• Goal: To detect the presence of IgA-class antibodies against the endomysium.
• Main Application: Diagnosing Celiac disease, differentiating it from other malabsorption syndromes, and monitoring adherence to a gluten-free diet.
• Method: Indirect Immunofluorescence (IIF) — a specialized technique where the patient’s serum is applied to tissue sections and viewed under a microscope.

Collection Recommendations (General)

• Timing: Blood collection is best performed in the morning.
• Fasting: Overnight fasting (8–12 hours) is recommended; plain water is allowed.
• Material: Venous blood (serum).
• Specific Rules: Crucial: You must be on a gluten-containing diet (eating bread, pasta, etc.) for at least several weeks before the test. If you have already started a gluten-free diet, the antibodies may disappear, leading to a false-negative result.

Factors Influencing the Result

• IgA Deficiency: About 2–3% of people with Celiac disease also have a “Selective IgA Deficiency.” Since the EMA test usually measures the IgA subclass, these patients will test negative even if they have the disease. In such cases, total IgA must be measured.
• Dietary Compliance: If a person with Celiac disease stops eating gluten, EMA levels typically drop to undetectable levels within 3–6 months.
• Age: The test may be slightly less sensitive in very young children (under 2 years old).

When to Take This Test?

• Recommendations: If you have chronic diarrhea, unexplained weight loss, persistent bloating, iron-deficiency anemia that doesn’t improve with supplements, or a family history of Celiac disease.
• Importance: EMA has a specificity of nearly 100%, meaning a positive result almost certainly indicates Celiac disease.

Medical Interpretation

• Crucial Note: The interpretation of EMA results is a specialized clinical task. Because it is a “qualitative” test (reported as Positive or Negative), it requires an experienced pathologist to read the microscopic slides. Only a specialist can “fine-tune” these results by correlating them with your symptoms and other antibody levels.
• Positive Result: Highly indicative of Celiac disease or Dermatitis Herpetiformis.
• Negative Result: Usually rules out Celiac disease, provided the patient was eating gluten and does not have an IgA deficiency.

Possible Further Investigations

• Anti-Tissue Transglutaminase (tTG) IgA: Often performed alongside EMA as a primary screening tool.
• Total IgA: To ensure the patient produces enough IgA for the test to be valid.
• Genetic Testing (HLA-DQ2/DQ8): To see if the patient has the genetic “blueprint” required to develop Celiac disease.
• Small Bowel Biopsy: The “gold standard” to confirm the diagnosis by looking for villous atrophy in the intestine.
• Consultation with a Gastroenterologist.

When Does the Next Step Make Sense?

• If the EMA test is positive, the next step is usually an endoscopy with a biopsy to confirm the extent of intestinal damage. Once a diagnosis is confirmed, the only treatment is a lifelong, strict gluten-free diet.
• All clinical decisions must be made by a healthcare professional based on both laboratory findings and the clinical response to dietary changes.

👉 If necessary, you can discuss the analysis results with a specialist such as a gastroenterologist (Doctors – TAMC) or immunologist (Doctors – TAMC).